STOCK TITAN

Neogen Corp - NEOG STOCK NEWS

Welcome to our dedicated page for Neogen news (Ticker: NEOG), a resource for investors and traders seeking the latest updates and insights on Neogen stock.

Overview

Neogen Corporation (NASDAQ: NEOG) is a globally recognized company that develops, manufactures, and markets innovative solutions dedicated to enhancing food and animal safety. The company is renowned for its comprehensive diagnostics and testing platforms, which are designed to detect contaminants, pathogens, allergens, and other harmful substances in both food and animal feed. Its products span a wide range of applications including culture media, diagnostic test kits, veterinary instruments, and molecular assays. With a robust presence in key markets and a strong commitment to scientific advancement, Neogen plays a crucial role in safeguarding public health and ensuring the quality and safety of agricultural products worldwide. In the highly specialized industries of food processing and veterinary diagnostics, its advanced diagnostic testing and molecular detection offerings have positioned it as a trusted partner for producers, laboratories, and regulatory agencies alike.

Food Safety Solutions

The Food Safety division of Neogen is engineered to provide a wide array of testing solutions to detect foodborne contaminants. The company markets a diverse portfolio including dehydrated culture media and diagnostic kits that enable rapid identification of pathogens such as bacteria, natural toxins, allergens, and chemical residues. These products are designed for food processors and feed manufacturers who require precise and quick results to ensure that their products meet stringent safety standards. Neogen leverages advancements in isothermal DNA amplification technology and bioluminescence detection, facilitating efficient and accurate assays that are indispensable for maintaining high-quality food production. By integrating state-of-the-art research with reliable testing protocols, Neogen fortifies food safety programs across the globe.

Animal Safety and Veterinary Diagnostics

The Animal Safety division is dedicated to enhancing the health and well-being of livestock and pets. Neogen offers a comprehensive line of products ranging from diagnostic instruments to veterinary pharmaceuticals and nutritional supplements. The portfolio also includes advanced diagnostic tests used for assessing animal health parameters, pathogen detection in veterinary settings, and genomic tests designed to evaluate genetic predispositions in livestock. These solutions are developed to support veterinarians, livestock producers, and agricultural operations, helping them to swiftly diagnose diseases and manage health risks. A keen focus on biosecurity and contamination prevention has propelled its animal care solutions to be highly respected in the veterinary community.

Technological Innovation and Advanced Diagnostics

Central to Neogen's value proposition is its commitment to technological innovation. The company’s advanced molecular detection platforms utilize cutting-edge techniques such as loop-mediated isothermal DNA amplification (LAMP) to deliver rapid results and high accuracy in pathogen detection. This technology is not only applied in food safety testing, but also extends to initiatives in genomics, facilitating comprehensive evaluations that inform both human and animal health practices. Neogen continuously updates its product offerings through thoughtful integration of new technologies, which has included the incorporation of automated systems designed to enhance laboratory productivity. These technological advancements contribute to streamlined workflows and reduced manual processing errors, thereby increasing testing throughput in high-volume laboratory environments.

Quality Assurance and Safety Standards

Quality and consistency are at the heart of Neogen's operations. The company employs rigorous quality assurance processes, integrating industry-standard certifications and validations from globally recognized organizations. These measures ensure that every test kit, culture media, and diagnostic instrument meets the highest standards of accuracy and reliability. Neogen's products undergo extensive performance testing and are supported by a dedicated network of scientists and technical experts, which bolsters its reputation as an authority in the field. By adhering to stringent regulatory requirements, Neogen not only minimizes risks associated with foodborne illnesses and animal diseases but also builds long-term trust among its customers and stakeholders.

Global Reach and Market Significance

With a presence in over 140 countries, Neogen Corporation is a key player in the global market for food and animal safety solutions. Its widespread distribution network and close relationships with customers across different regions enable the company to address diverse market needs. In addition, Neogen's strategic integrations and investments in research and development have allowed it to expand its product portfolio and reinforce its competitive position. The company’s commitment to advancing global food security is demonstrated through its strategic product launches and collaborations with industry regulators and laboratories. This extensive market reach, combined with deep technical expertise, positions Neogen as an essential component of modern food safety and veterinary practices worldwide.

Operational Strengths and Integrated Solutions

Neogen leverages its integrated business model by combining advanced scientific research with practical customer solutions. The company’s recent integration initiatives have further enhanced its operational capabilities, ensuring that products from different divisions complement each other to provide a full spectrum of safety solutions. Whether it is through its streamlined laboratory automation systems or its comprehensive approach to pathogen and allergen detection, Neogen has established a robust ecosystem that supports both high-efficiency operations and scalable quality outcomes. Customers benefit from a one-stop solution provider that offers end-to-end services—from initial sample processing to final result analysis—thereby reducing the risk of contamination and ensuring compliance with international safety standards.

Commitment to Scientific Research and Industry Expertise

At the core of Neogen's business strategy is a deep commitment to research and innovation. The company dedicates substantial resources to scientific exploration and maintains relationships with academic institutions, regulatory bodies, and industry partners. This collaborative approach enables Neogen to continually refine its technologies and expand its product offerings in response to evolving market needs. As a result, Neogen not only addresses current safety challenges but also anticipates and adapts to emerging trends in food safety and animal diagnostics. Its broad portfolio is supported by a team of experts who ensure that each product is underpinned by rigorous scientific research, thereby reinforcing the company's position as an authority in the field and providing a trusted shield against contamination and disease risks.

Industry Impact and Customer-Centric Approach

Neogen's influence extends well beyond its product offerings. Through a customer-centric approach, the company drives enhancements that benefit the entire food safety and veterinary sectors. Its consultative methods and robust technical support ensure that end users—ranging from large-scale food processors to individual veterinary practitioners—receive tailored solutions that meet their specific challenges. By providing continuous education and training through technical seminars and direct customer interaction, Neogen reinforces its reputation as a reliable and trusted partner in the field. Its comprehensive portfolio and focused expertise empower customers to implement effective safety programs, minimize risks, and maintain operational excellence in competitive and regulatory-driven markets.

Summary

Neogen Corporation stands at the intersection of science and practical application, driving forward innovations that ensure safer food production and healthier animals. Through its dual focus on food and animal safety, advanced diagnostic techniques, and commitment to quality assurance, Neogen has established itself as a pivotal force in global food security. Emphasizing technological innovation, operational integration, and a customer-first philosophy, the company continues to set benchmarks in the industry, truly embodying the ideals of expertise, experience, authoritativeness, and trustworthiness. The depth and breadth of its product portfolio, combined with a strategic global presence, make Neogen Corporation a critical contributor to both public health initiatives and the advancement of modern agricultural practices. Investors and industry professionals alike recognize Neogen for its scientific rigor, quality innovations, and commitment to addressing the ongoing challenges in food safety and animal health markets.

Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) has revealed the recipients of its Supervised Agricultural Experience (SAE) Grants, funded through a partnership with the National FFA Foundation. From October 1, 2021, to March 31, 2022, the company pledged $2 per bottle sold of its Prozap StandGuard Pour-On product. Ten FFA chapters nationwide each received $1,000 to support agricultural projects, along with an additional $1,000 for their chapters. Neogen's President, John Adent, emphasized the importance of nurturing future leaders in agriculture, while FFA's Molly Ball praised the company's commitment to developing skills for the members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
partnership
-
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) reported a revenue of $230.0 million for Q2 of fiscal 2023, reflecting a 76.2% increase year-over-year. The net income was $(41.8) million or $(0.19) per share, impacted by transaction costs related to its merger with 3M's Food Safety Division. Adjusted Net Income reached $31.4 million or $0.15 per share. The adjusted EBITDA was $64.1 million with a margin of 27.8%. Food Safety revenues soared to $161.3 million, a 140.3% increase, while Animal Safety recorded $68.7 million, up 8.4%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
none
-
Rhea-AI Summary

Neogen Corporation announced its participation in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 11, 2023. Neogen's President and CEO, John Adent, will present at 8:15 a.m. Pacific Time. Interested parties can access the presentation materials and webcast through the Neogen Investor Relations website.

Neogen specializes in food and animal safety solutions, offering diagnostic test kits and genomic products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.48%
Tags
conferences
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) will release its second-quarter earnings on January 5, 2023, before market opening. A conference call is scheduled for 8:00 a.m. Eastern time the same day for discussion of the financial results. Interested participants can join the call by dialing 1.844.757.5681 in the U.S. or 1.412.317.5297 internationally, using Conference ID 10173804. A live webcast will also be available through Neogen's Investor Relations webpage.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
-
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) has announced the receipt of the Performance Tested Method Certification from the AOAC Research Institute for its Reveal® 3-D for Gluten test. This certification validates that the test meets AOAC standards for detecting gluten residues in environmental samples. Additionally, it is accepted for use in processes governed by the Gluten Free Certification Organization (GFCO). Neogen's Reveal 3-D for Gluten provides a rapid and reliable method for detecting gluten at levels as low as 5 parts per million, supporting gluten-intolerant consumers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
none
-
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) will participate in the Piper Sandler 34th Annual Healthcare Conference in New York City on November 30, 2022. John Adent, President and CEO, is scheduled to present at 8:00 a.m. Eastern Time. Interested parties can access the webcast and presentation materials on the Neogen Investor Relations website. Neogen focuses on food and animal safety, offering solutions including diagnostic test kits and genomic products for animal health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
conferences
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) has launched its upgraded Ideal® D3™ detectable needles, which are now six times more detectable than standard needles. The patent-pending D3X design features stronger side walls to reduce bending and a highly visible red extraction collar that enhances safety by making broken needles easier to retrieve. CEO John Adent emphasized that these improvements increase efficiency and food safety for production farmers. Neogen continues to support animal care with innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
none
-
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) has launched its Synergize disinfectant in Europe, the Middle East, and Africa, expanding its biosecurity products trusted in North America for over 20 years. Synergize is effective against various pathogens, including bacteria, fungi, and viruses, and is approved by regulatory bodies such as the U.S. EPA and UK DEFRA. The product will debut at the EuroTier exhibition in Hannover, Germany. Neogen aims to enhance global biosecurity measures, ensuring the safety of the food chain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
none
-
Rhea-AI Summary

Neogen Corporation has renewed its partnership with the National FFA to support the 2023 Supervised Agricultural Experience (SAE) Grants. Under the agreement, Neogen will donate $2 for every bottle of Prozap StandGuard Pour-On sold, with a total contribution cap of $250,000. The program aims to provide $1,000 grants to FFA members, fostering agricultural education and leadership. Neogen emphasizes its commitment to supporting future leaders in agriculture, showcasing its dedication to community involvement and youth development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
none
Rhea-AI Summary

Neogen Corporation (NASDAQ: NEOG) has launched K-Blue Luminescent ONE, a ready-to-use chemiluminescent substrate that enhances efficiency in immunoassay production. This innovative substrate simplifies workflows by eliminating mixing errors and reducing plastic waste, with high sensitivity from nanograms to picograms. K-Blue Luminescent ONE complies with strict regulatory standards and is developed under an ISO 9001-certified system, ensuring excellent consistency. With 30 years of experience in ELISA tests, Neogen continues to provide reliable solutions in food and animal safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none

FAQ

What is the current stock price of Neogen (NEOG)?

The current stock price of Neogen (NEOG) is $8.39 as of April 1, 2025.

What is the market cap of Neogen (NEOG)?

The market cap of Neogen (NEOG) is approximately 1.8B.

What is the primary focus of Neogen Corporation?

Neogen Corporation specializes in developing and marketing diagnostic solutions for food safety and animal health, ensuring the detection of contaminants and enhancing overall safety standards.

How does Neogen support food safety?

The company offers a range of products including dehydrated culture media and diagnostic test kits designed to detect foodborne pathogens, allergens, toxins, and other harmful substances in food and feed.

What technologies does Neogen utilize in its diagnostic testing?

Neogen employs advanced molecular detection technologies such as isothermal DNA amplification and bioluminescence detection, ensuring rapid and accurate testing of food and animal samples.

Which markets does Neogen serve?

Neogen serves a global market with a strong presence in the United States and Europe, providing products and solutions to food processors, diagnostic laboratories, veterinary practices, and agricultural operations.

What makes Neogen's animal safety division unique?

Neogen's animal safety division offers a comprehensive range of veterinary instruments, pharmaceuticals, nutritional supplements, and diagnostic tests, all designed to ensure the health and well-being of livestock and pets.

How does Neogen ensure the quality and reliability of its products?

The company adheres to stringent quality assurance protocols and global regulatory standards, supported by extensive research and a dedicated team of technical experts to validate and improve its product offerings.

What role does innovation play in Neogen's operations?

Innovation is central to Neogen's strategy, driving the development of cutting-edge diagnostic tools and automated systems that enhance testing efficiency, accuracy, and overall operational productivity.

How does Neogen contribute to global food security?

By providing reliable and advanced food safety solutions, Neogen helps prevent contamination, supports regulatory compliance, and ensures that food products meet high safety standards, thereby contributing to global food security.
Neogen Corp

Nasdaq:NEOG

NEOG Rankings

NEOG Stock Data

1.81B
216.32M
0.27%
121.87%
10.66%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING